In both responsive animal models, tumor-growth inhibition came along with an upregulation of CaSR expression, corroborating previously published data, demonstrating that calcimimetics modulate both the expression and activity of CaSR [9,15,16]. The gene discussed is CASR; the disease is neoplasm.